Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
schizophrenia
Research
Autoreceptor absence fuels dopamine dysfunction in schizophrenia
Scientists believe they've identified the mechanism that underlies the dopamine hypothesis of schizophrenia.
Helen Floersh
Nov 1, 2022 11:00am
Merck gains Moderna's cancer shot, signs Royalty collab
Oct 12, 2022 10:55am
Karuna hits goal in schizophrenia phase 3, teeing up 2023 filing
Aug 8, 2022 9:48am
Biogen CEO points to risk in neuroscience as 3 programs cut
Jul 20, 2022 11:12am
BioXcel enters $260M finance deal–but terms apply
Apr 20, 2022 9:30am
Researchers link genes to schizophrenia using trove of new data
Apr 6, 2022 11:26am
